2008 Bonus Awards RSU Grant Summary for Named Executive Officers

Summary

This document outlines the 2008 bonus awards for the company's named executive officers, specifying that instead of cash bonuses, each officer received restricted stock units (RSUs) under the 2005 Equity Incentive Plan. The RSUs were granted based on the cash bonus amount, using the company's stock price as of January 14, 2009. The RSUs are fully vested immediately upon grant and may be settled in company stock. The officers named include the CEO, CFO, President, and Senior Vice Presidents.

EX-10.25.1 2 f51118exv10w25w1.htm EX-10.25.1 exv10w25w1

Exhibit 10.25.1

Named Executive Officer Compensation Information — 2008 Bonus Awards

The table below provides information regarding the RSUs granted to the Company’s named executive officers in lieu of cash payments under the Bonus Plan for the 2008 performance period:


	Value of Cash		RSU Equivalent
Named Executive Officer	Bonus Award (1)		Grant (2)
*Ronald W. Barrett, PhD*	$	266,250.00		9,872
Chief Executive Officer
*William G. Harris*	$	82,687.50		3,065
Senior Vice President of Finance and Chief Financial Officer
*William J. Rieflin*	$	150,820.31		5,592
President
*Kenneth C. Cundy, PhD*	$	83,737.50		3,104
Senior Vice President of Preclinical Development
*David R. Savello, PhD*	$	81,600.00		3,025
Senior Vice President of Development


(1)		Cash Bonus Award amounts determined under the Bonus Plan for the 2008 performance period.

(2)		RSUs granted pursuant to the 2005 Equity Incentive Plan at the close of trading on January 14, 2009 at $26.97 per share (the closing stock price of the Company’s common stock on the Nasdaq Global Select Market), rounded down to the nearest whole share (no fractional shares were issued). The RSUs, which may be settled in stock, are immediately vested in full at the time of grant.